Why the study?
Differences observed in the pathophysiological mechanism, clinical presentation, risk factors, and therapeutic treatments of ischemic heart disease between women and men motivated a review for a more optimal approach in women.
What are the differences in pathophysiological mechanisms, clinical presentation, risk factors, and therapeutic treatments of ischemic cardiomyopathy between women and men?
What are the differences in pathophysiological mechanisms, clinical presentation, risk factors, and therapeutic treatments of ischemic cardiomyopathy between women and men?
Answers are grounded in this paper and cite their sources.
This narrative review emphasizes the need for a sex-specific approach to ischemic cardiomyopathy, recognizing distinct pathophysiological and clinical differences in women compared to men.
Ischemic heart disease is a clinically relevant entity in both men and women. However, differences have been observed in the pathophysiological mechanism in women, which determine a clinical presentation, risk factors and therapeutic treatments that may vary with respect to men. A narrative review has been carried out that reveals these differences in order to carry out a more optimal approach to ischemic cardiomyopathy in women.
No takes yet. Share an insight, caveat, or question.
Revueltas-Jiménez et al. (2022) conducted a review in Ischemic cardiomyopathy. Female sex vs. Male sex was evaluated.
Synapse has enriched 10 related papers. Consider them for comparative context: